Hims jumps after RFK Jr. announces FDA may loosen regulations for 12 peptides

The stock is still down more than 20% from the start of the year through yesterday’s close, taking a massive hit after its botched rollout of a copycat Wegovy pill.

Source: Sherwood News.

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *